Life-Changing Vaccine: World's First Recipient Shares Hope in Breast Cancer Elimination

Jennifer Davis, the first American woman to receive a vaccine aimed at preventing recurring bouts of triple-negative breast cancer, has reported that it has changed her life. The vaccine, developed by the Cleveland Clinic, targets a lactation protein found in breast milk and triple-negative breast cancer cells. Davis, who has been in remission for five years, credits the vaccine with eliminating her fear of recurrence. The clinical trial is now focusing on recruiting women at higher risk of developing triple-negative breast cancer to determine if the vaccine can prevent the cancer from occurring in the first place.